Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration
Authors:
- Andreas BeckerABAndreas Becker
- Stephanie KohlmannSKStephanie Kohlmann
- Anca AlexandruAAAnca Alexandru
- Wolfgang JaglaWJWolfgang Jagla
- Fabio CannevaFCFabio Canneva
- Christoph BäuscherCBChristoph Bäuscher
- Holger CynisHCHolger Cynis
- Reinhard SedlmeierRSReinhard Sedlmeier
- Sigrid GraubnerSGSigrid Graubner
- Stephan SchillingSSStephan Schilling
- Hans-Ulrich DemuthHDHans-Ulrich Demuth
- Stephan von HörstenSHStephan von Hörsten
Open Access
- 1 October 2013
- journal article
- Published by Springer Nature in BMC Neuroscience
- Vol. 14 (1) , 108
Abstract
Background: Posttranslational modifications of beta amyloid (Aβ) have been shown to affect its biophysical and neurophysiological properties. One of these modifications is N-terminal pyroglutamate (pE) formation. Enzymatic glutaminyl cyclase (QC) activity catalyzes cyclization of truncated Aβ(3-x), generating pE3-Aβ. Compared to unmodified Aβ, pE3-Aβ is more hydrophobic and neurotoxic. In addition, it accelerates aggregation of other Aβ species. To directly investigate pE3-Aβ formation and toxicity in vivo, transgenic (tg) ETNA (E at the truncated N-terminus of Aβ) mice expressing truncated human Aβ(3–42) were generated and comprehensively characterized. To further investigate the role of QC in pE3-Aβ formation in vivo, ETNA mice were intercrossed with tg mice overexpressing human QC (hQC) to generate double tg ETNA-hQC mice. Results: Expression of truncated Aβ(3–42) was detected mainly in the lateral striatum of ETNA mice, leading to progressive accumulation of pE3-Aβ. This ultimately resulted in astrocytosis, loss of DARPP-32 immunoreactivity, and neuronal loss at the sites of pE3-Aβ formation. Neuropathology in ETNA mice was associated with behavioral alterations. In particular, hyperactivity and impaired acoustic sensorimotor gating were detected. Double tg ETNA-hQC mice showed similar Aβ levels and expression sites, while pE3-Aβ were significantly increased, entailing increased astrocytosis and neuronal loss. Conclusions: ETNA and ETNA-hQC mice represent novel mouse models for QC-mediated toxicity of truncated and pE-modified Aβ. Due to their significant striatal neurodegeneration these mice can also be used for analysis of striatal regulation of basal locomotor activity and sensorimotor gating, and possibly for DARPP-32-dependent neurophysiology and neuropathology. The spatio-temporal correlation of pE3-Aβ and neuropathology strongly argues for an important role of this Aβ species in neurodegenerative processes in these models.Keywords
This publication has 43 references indexed in Scilit:
- Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-βNature, 2012
- Pyroglutamate Amyloid β (Aβ) Aggravates Behavioral Deficits in Transgenic Amyloid Mouse Model for Alzheimer DiseaseJournal of Biological Chemistry, 2012
- Proteolytic processing of Alzheimer’s β‐amyloid precursor proteinJournal of Neurochemistry, 2011
- Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviorsProceedings of the National Academy of Sciences, 2010
- Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's diseaseNeurobiology of Disease, 2010
- Glutaminyl Cyclases Display Significant Catalytic Proficiency for Glutamyl SubstratesBiochemistry, 2009
- Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse modelActa Neuropathologica, 2009
- Isolation of an Isoenzyme of Human Glutaminyl Cyclase: Retention in the Golgi Complex Suggests Involvement in the Protein Maturation MachineryJournal of Molecular Biology, 2008
- Behavioral phenotyping of mice in pharmacological and toxicological researchExperimental and Toxicologic Pathology, 2003
- Alzheimer’s Disease as Proteolytic Disorders: Anabolism and Catabolism of β-AmyloidNeurobiology of Aging, 1998